Mobile Phone-based Intervention to promote un-interrupted HIV treatment during the COVID-19 pandemic.
Antiretroviral therapy
Chronic HIV treatment
M-Health
patient follow up
Journal
African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
entrez:
2
11
2022
pubmed:
3
11
2022
medline:
4
11
2022
Statut:
ppublish
Résumé
Keeping HIV-infected adults away from the health care system during the COVID-19 travel restrictions, presents a challenge to HIV treatment adherence. This study focused on the initial two phases where Phase 1 designed a Makerere College of Health Sciences (MakCHS) Unstructured Supplementary Service Data (USSD)-based application; and Phase 2 piloted patient enrolment onto the application and determined the feasibility of remote follow-up of patients receiving long-term antiretroviral therapy (ART). A off/online user application, MakCHS Health app, was developed. Overall, 112 patients [(66(59%) female] receiving ART at Mulago ISS clinic, Kampala, were enrolled onto the MakCHS Health app. Up to 89 (80%) utilized the app to access medical help. Patients' medical queries included needs for drug refills, missed taking HIV medication, medical illnesses, access to COVID-19 vaccination and other personal needs that required clinicians' attention. Piloting a MakCHS Health application for patient follow-up was feasible and well-received by HIV treatment providers and patients receiving ART. We recommend scale up of the application to enroll all patients receiving long-term treatment for HIV/AIDS, and subsequently expand to. other HIV treatment programs in similar settings.
Identifiants
pubmed: 36321123
doi: 10.4314/ahs.v22i2.14S
pii: jAFHS.v22.i2.pg85S
pmc: PMC9590328
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
85-92Informations de copyright
© 2022 Nakanjako D et al.
Références
Ann Glob Health. 2020 Jul 28;86(1):85
pubmed: 32832383
BMC Immunol. 2021 Aug 26;22(1):59
pubmed: 34445953
J Infect Dis. 2019 Sep 26;220(9):1414-1419
pubmed: 31323092
AIDS. 2016 Jul 31;30(12):1913-22
pubmed: 26959510
Clin Immunol. 2019 Apr;201:55-60
pubmed: 30817998
Drugs. 2002;62(2):245-53
pubmed: 11817971
PLoS One. 2019 Jul 3;14(7):e0219141
pubmed: 31269070
BMC Immunol. 2013 Jun 20;14:26
pubmed: 23786370